About G.D. Pharmaceuticals Private Limited
Data last updated:
G.D. Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 01 April 1955 and has been in existence for over 71 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1955PTC022265. Its GSTIN is 19AABCG3397A1ZQ (West Bengal). The company holds 15 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹90 Lakh. It was formerly known as G.D. Pharmaceuticals Limited. It is led by directors including Debashis Dutta (Managing Director) and Pratik Mukherjee (Whole-Time Director).
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 94 Nalini Ranjan Avenue, Kolkata, West Bengal, India – 700053.
As per the financials filed for FY 2025, the company reported a revenue of ₹334.15 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹116.66 Cr (net margin 34.9%) and EBITDA of ₹157.23 Cr (EBITDA margin 47.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 212 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Boroline. As per MCA filings, the company has satisfied charges of ₹15 Cr on record. Court records list 27 cases involving the company, including 21 filed by the company and 6 filed against it; 2 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in August 2022. Its 4 peer companies in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger; the largest is Mepro Pharmaceuticals Private Limited with revenue of ₹356.46 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website boroline.com.
Company details
Contact details
G.D. Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its website is boroline.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address94 Nalini Ranjan Avenue, Kolkata, West Bengal, India – 700053
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of G.D. Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
G.D. Pharmaceuticals operates one associated brand: Boroline. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Boroline manufactures Ayurvedic skin creams, lotions, soaps and hair oils. | boroline.com |
Business activity
The main business activity of G.D. Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of G.D. Pharmaceuticals Private Limited, buy the company report.
Financials of G.D. Pharmaceuticals Private Limited
FY 2025 filings availableG.D. Pharmaceuticals Private Limited reported revenue of ₹334.15 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 26% growth in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹157.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹116.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 47.1% | ||||
| Net Profit Margin | 34.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of G.D. Pharmaceuticals Private Limited, buy the company report.
Board of directors of G.D. Pharmaceuticals Private Limited
G.D. Pharmaceuticals has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratik Mukherjee | Whole-Time Director | 06 Aug 2019 | 7 Years 2 Months | Current |
| Debashis Dutta Also directs: Murabela Fashion Private Limited, B M Computer Aids Pvt Ltd | Managing Director | 01 Oct 2021 | 5 Years 1 Months | Current |
| Suman Bagchi | Whole-Time Director | 01 Jul 2024 | 2 Years 4 Months | Current |
| Mahashweta Dutta Also directs: Murabela Fashion Private Limited, B M Computer Aids Pvt Ltd | Whole-Time Director | 01 Sep 1998 | 28 Years 2 Months | Current |
| Tushar Kar | Whole-Time Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Saumitra Pal | Whole-Time Director | 01 May 2014 | 12 Years 6 Months | Current |
Peer comparison
G.D. Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mepro Pharmaceuticals Private Limited | ₹356.46 Cr (FY 2025) | 20.0% | Surendra Nagar, Gujarat, India | |||
| Geno Pharmaceuticals Private Limited | ₹349.47 Cr (FY 2025) | 14.0% | Goa, India | |||
| Stella Indusstries Limited | ₹341.73 Cr (FY 2024) | 70.0% | New Delhi, Delhi, India | |||
| Ozone Pharmaceuticals Limited | ₹337.45 Cr (FY 2025) | -1.0% | New Delhi, Delhi, India | |||
| G.D. Pharmaceuticals Private Limitedthis company | ₹334.15 Cr (FY 2025) | ₹116.66 Cr | 34.9% | 26.0% | 212 | Kolkata, West Bengal, India |
To see the full peer comparison of G.D. Pharmaceuticals Private Limited, buy the company report.
Auditor
G.D. Pharmaceuticals Private Limited is audited by P. Mukherjee & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P. Mukherjee & Co. | FY 2024 | 304143E |
Shareholding
The shareholding of G.D. Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of G.D. Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Aug 2016 | 100049092 | Others | ₹10 Cr | Satisfied | |
| 31 Aug 2015 | 10592772 | Dbs Bank Ltd. | ₹5 Cr | Satisfied |
To see the full charge records of G.D. Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
G.D. Pharmaceuticals Private Limited has 2 deals on record (2 secondary share transfers); the latest was in August 2022.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
G.D. Pharmaceuticals Private Limited has 27 court cases on record: 21 filed by G.D. Pharmaceuticals, 6 filed against it. 2 cases are pending and 25 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 18 | 1 | 1 |
| District courts | 7 | 3 | 1 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Helbrede Healthcare Ltd & Anr. | Disposed |
| Calcutta High Court | Civil suit | Filed by the company against Calcutta Extrusions Private Limited | Disposed |
| District court, Calcutta, West Bengal | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| Calcutta High Court | Writ petition | Filed by the company against State of West Bengal & Ors | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against M/S Cento Products (India) | Disposed |
To see the full case history of G.D. Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for G.D. Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
G.D. Pharmaceuticals Private Limited has a workforce of 212 employees on its EPFO records as of Sep 23, 2025, across 2 active EPFO establishments.
GST
G.D. Pharmaceuticals has 15 GST registrations: 3 active and 12 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCG3397A1ZQ | West Bengal | Active | 01 Jul 2017 |
| 19AABCG3397A2ZP | West Bengal | Active | 04 Oct 2018 |
| 09AABCG3397A1ZR | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of G.D. Pharmaceuticals Private Limited, buy the company report.
Recent activity
G.D. Pharmaceuticals Private Limited has 15 board changes on record since 1998: 7 appointments and 8 cessations. The latest: Amitava Ghosh was appointed as Whole-Time Director on 02 Feb 2026.
10 earlier events are in the company report.
Frequently asked questions
G.D. Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 01 April 1955 (71+ years old) and is registered under CIN U24231WB1955PTC022265.
G.D. Pharmaceuticals has 7 current directors:
- Debashis Dutta - Managing Director
- Pratik Mukherjee - Whole-Time Director
- Suman Bagchi - Whole-Time Director
- Mahashweta Dutta - Whole-Time Director
- Tushar Kar - Whole-Time Director
- Saumitra Pal - Whole-Time Director
- Amitava Ghosh - Whole-Time Director
The latest financial statements of G.D. Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of G.D. Pharmaceuticals is 19AABCG3397A1ZQ, registered in West Bengal. The company has 15 GST registrations in all, of which 3 are active and 12 are cancelled or inactive. Other active GSTINs include 19AABCG3397A2ZP (West Bengal), 09AABCG3397A1ZR (Uttar Pradesh).
The CIN (Corporate Identification Number) of G.D. Pharmaceuticals is U24231WB1955PTC022265. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
G.D. Pharmaceuticals has 27 court cases on record: 21 filed by the company and 6 filed against it. 2 are pending. Most are in the high courts.
G.D. Pharmaceuticals was incorporated on 01 April 1955, making it 71+ years old. It is registered with the Registrar of Companies, Kolkata.
G.D. Pharmaceuticals has 2 deals on record (2 secondary share transfers); the latest was in August 2022.
The peers of G.D. Pharmaceuticals by revenue are Mepro Pharmaceuticals Private Limited, Geno Pharmaceuticals Private Limited, Stella Indusstries Limited, Ozone Pharmaceuticals Limited, all in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amitava Ghosh was appointed as Whole-Time Director on 02 Feb 2026. Suman Bagchi was appointed as Whole-Time Director on 01 Jul 2024. Tushar Kar was appointed as Whole-Time Director on 16 Mar 2023. G.D. Pharmaceuticals has 15 board changes on record in total.
G.D. Pharmaceuticals can be reached through the website boroline.com. Its registered office is in Kolkata, West Bengal, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
